Priv.-Doz. Dr. Johannes Kerschbaumer, PhD

Neurochirurgie

• „Distance to the neurooncological centre: a new prognostic parameter in GBM patients?” – DGNC Jahrestagung 2012, Leipzig, Deutschland


• „Korrelation zwischen Tumorvolumen und Volumen des peritumoralen Ödems bei zerebralen Metastasen“ – ÖGNC Jahrestagung 2014, Wien, Österreich


• „Work in progress – Floureszenzunterstützte Resektion“ – SANO Neuroonko Update 2015, Salzburg, Österreich


• „Hormone-dependent Shrinkage of a Sphenoid Wing Meningioma after Pregnancy” – SANO Neuroonko Update 2015, Salzburg, Österreich


• Korrelation zwischen Tumorvolumen und Volumen des peritumoralen Ödems bei zerebralen Metastasen“ – DGNC Jahrestagung 2015, Karlsruhe, Deutschland


• „Intraoperatives CT und Navigation in der transnasalen Hypophysenchirurgie“ – Patiententag 2015, Innsbruck, Österreich


• „Sector irradiation vs. whole-brain irradiation after resection of singular brain metastasis – interim analysis of a prospective randomized monocentric trial” – DGNC Jahrestagung 2016, Frankfurt a.M., Deutschland


• “Erste Erfahrungen mit Yellow 560 bei der Resektion von Hirnmetastasen“ – ANCO meeting 2017, Innsbruck, Österreich


• “Evaluation of 31P-MR-Spectroscopy in brain metastases correlated to histopathological results” – Kongress DGC 2018, Berlin, Deutschland


• “Sector irradiation vs. whole-brain irradiation after resection of singular brain metastasis – a prospective randomized monocentric trial” – EANS annual meeting 2018, Brüssel, Belgien


• “First experiences with phosphorus spectroscopy in gliomas” – ANCO meeting 2018, Wien, Österreich


• “Evaluation of 31P-MR-Spectroscopy in brain metastases correlated to histopathological results” – ÖGNC Jahrestagung 2018, Feldkirch, Österreich


• “Surgery for meningioma” – AAF meeting 2019, Salzburg, Österreich


• “Floureszenzgestütztes Operieren” – ÖCK Jahrestagung 2019, Innsbruck, Österreich


• „Korrelation von Bildgebung und molekularen Markern mit der Lokalisation bei Patienten mit niedriggradigem Gliom“ – ÖGNC Jahrestagung 2020, Wr. Neustadt, Österreich


• „Frontal vs temporal and/or insular location in LGG” – EANS annual meeting 2020 (virtual)


• “Recurrence pattern of surgically treated brain metastases after local postoperative radiotherapy” – EANS annual meeting 2020 (virtual)


• „Radionekrosen nach stereotaktischer Bestrahlung von Hirnmetastasen“ – ÖGNC Jahrestagung 2020, Klagenfurt, Österreich


• “Key preoperative prognostic factors for overall survival in patients with brain metastasis” - DGNC Jahrestagung 2022, Köln, Deutschland


• “Auftreten einer Radionekrose nach stereotaktischer Bestrahlung von benignen Tumoren der Schädelbasis vs. Konnvexität: eine Analyse von 205 Patienten“ - DGNC Jahrestagung 2023, Stuttgart/Tübingen, Deutschland

• EANS – Young neurosurgeons CME meeting 02.2012


• „Anatomische Grundlagen für die Neurochirurgie“, Salzburg 03.2012


• Craniotomy course, Bern 11.2012


• „Microsurgery – Basis Course“, Basel 03.2013


• „Teamtraining Neurosurgery“, ESI Hamburg 05.2013


• EANS-trainings courses
  
  
  
  • “Vascular neurosurgery“, Prague 09.2013
  
  
  •  “Tumor”, Nikosia 09.2014
  
  
  •  “Head Injury/Functional”, Lisbon 09.2015
  
  
  • “Spine”, Berlin 09.2016
  
  
  
  


• Diploma „Prüfarzt“, ÄK Tirol 11.2013


• "White matter dissection course“– Graz 02.2014


• Observership at the Barrow Neurological Institut, Phoenix, AZ 11.2016


• The 17^th Helsinki Live Demonstration Course in Operative Microneurorugery 06.2017


• 360-Degree Skull base course, Strasbourg 06.2021


• Pituitary Course 2023, Lyon 03.2023


• 14^th Tübinger Course of Neurosurgical Approaches (TCNA) 06.2023


• Additivfach Intensivmedizin ÖAK Diplom 06.2022

1.     Kerschbaumer J, Freyschlag CF, Bauer R, Obwegeser AA, Schubert GA, Thomé C, Seiz M. Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study. Anticancer Res. 2012 Dec; 32(12):5515-9. 

2.     Freyschlag CF, Goerke SA, Obernauer J, Kerschbaumer J, Thomé C, Seiz M. A Sandwich Technique for Prevention of Cerebrospinal Fluid Rhinorrhea and Reconstruction of the Sellar Floor after Microsurgical Transsphenoidal Pituitary Surgery. J Neurol Surg A Cent Eur Neurosurg 2016 May;77(3):229-32. doi: 10.1055/s-0035-1547357. Epub 2015 19.

3.     Kerschbaumer J, Freyschlag CF, Stockhammer G, Taucher S, Maier H, Thomé C, Seiz M. Hormone-dependent Shrinkage of a Sphenoid Wing Meningioma After Pregnancy. J Neurosurg 2016 Jan;124(1):137-40. doi: 10.3171/2014.12.JNS142112. Epub 2015 Jul 10.

4.     Kerschbaumer J, Schmidt F, Grams AE, Nowosielski M, Pinggera D, Brawanski K, Petr O, Thomé C, Tuettenberg J, Seiz M, Freyschlag CF. Dual anti- angiogenic chemotherapy with temozolomide and celecoxib in selected patients with malignant glioma, not eligible for standard treatment. Anticancer Res. 2015 Sept;35(9):4955-60

5.     Kerschbaumer J, Freyschlag CF, Seiz M, Thomé C. Usefulness of intraoperative computed tomography in complication management after spine surgery. A case report. Ind J Neurosurg 2015. Nicht Pubmed gelistet

6.     Freyschlag CF, Kerschbaumer J, Thomé C. Maximizing the Extent of Resection in Gliomas: Intraoperative Awake Mapping Versus Intraoperative Imaging. European Association for Neuro-Oncology (EANO) magazine 2015. Nicht Pubmed gelistet

7.     Kerschbaumer J, Pinggera D, Moser P, Hofmann A, Thomé C, Freyschlag CF. Somatostatin treatment can induce extensive fibrosis in growth hormone-producing adenoma. Acta Neurochir (Wien) 2016 Mar;158(3):441-3. doi: 10.1007/s00701-016-2714-7. Epub 2016 Jan 23.

8.     Pinggera D, Kerschbaumer J, Innerhofer N, Woehrer A, Freyschlag CF, Thomé C. Disseminated intravascular coagulation in secondary glioblastoma due to excessive intraoperative bleeding – case report and review of the literature. Word Neurosurg. 2016 Jun;90:702.e7-702.e11. doi: 10.1016/j.wneu.2016.02.077. Epub 2016 Feb 26

9.     Gelpi E, Höftberger R, Würger T, Kerschbaumer J, Freyschlag CF, Djurdjevic T, Hainfellner JA. Clinical Neuropathology image 5-2016: neurofibrillary tangle-rich ganglioglioma. Clin Neuropathol. 2016 Sep-Oct;35(5):278-9. doi: 10.5414/NP300982

10.  Freyschlag CF, Kerschbaumer J, Eisner W, Thomé C. Optical Neuronavigation without Rigid Head Fixation during Awake Surgery. World Neurosurg. 2017 Jan;97:669-673. doi: 10.1016/j.wneu.2016.10.091. Epub 2016 Oct 27

11.  Pinggera D, Kvitsaridtze I, Stockhammer G, Eisner W, Thomé C, Freyschlag CF, Moser P, Kerschbaumer J. Serious tumor seeding after brainstem biopsy and its treatment – a case report and review of literature. Acta Neurochir (Wien) 2017 Apr;159(4):751-754. doi: 10.1007/s00701-017-3102-7. Epub 2017 Feb 2.

12.  Kerschbaumer J, Bauer M, Popovscaia M, Grams AE, Thomé C, Freyschlag CF. Correlation of Tumor and Peritumoral Edema Volumes with Survival in Patients with Cerebral Metastases. Anticancer Res. 2017 Feb;37(2):871-875. doi: 10.21873/anticanres.11392

13.  Kofler B, Kerschbaumer J, Schartinger VH, Posch A, Gizewski ER, Widmann G. Brain metastasis versus radiation necrosis after head and neck cancer: Brain lesion after head and neck cancer. Radiologe 2017 May;57(5):392-396. doi: 10.1007/s00117-017-0219-x

14.  Freyschlag CF, Kerschbaumer J, Pinggera D, Bacher G, Thomé C. Structured evaluation of glioma patients by an occupational therapist - is our clinical examination enough? World Neurosurg. 2017 Jul;103:493-500. doi: 10.1016/j.wneu.2017.04.033. Epub 2017 Apr 17.

15.  Freyschlag CF, Kerschbaumer J, Pinggera D, Bodner T, Grams AE, Thomé C. Preoperative prediction of language function by diffusion tensor imaging. Brain Inform. 2017 Sep;4(3):201-205. doi: 10.1007/s40708-017-0064-8. Epub 2017 May 4

16.  Petr O, Glodny B, Brawanski K, Kerschbaumer J, Freyschlag C, Pinggera D, Rehwald R, Hartmann S, Ortler M, Thomé C. Immediate versus Delayed Surgical Treatment of Lumbar Disc Herniation for Acute Motor Deficits: The Impact of Surgical Timing on Functional Outcome. Spine (Phila Pa 1976) 2019 Apr 1;44(7):454-463. doi: 10.1097/BRS.0000000000002295.

17.  Pinggera D, Kerschbaumer J, Petr O, Ortler M, Thomé C, Freyschlag CF. The volume of the third ventricle as a prognostic marker for shunt dependency after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2017 Dec;108:107-111. doi: 10.1016/j.wneu.2017.08.129. Epub 2017 Sep 1.

18.  Wostrack M, Ringel F, Eicker SO, Jägersberg M, Schaller K, Kerschbaumer J, Thomé C, Shiban E, Stoffel M, Friedrich B, Kehl V, Vajkoczy P, Meyer B, Onken J. Spinal ependymoma in adults: A multicenter investigation of surgical outcome and progression free survival. J Neurosurg Spine 2018 Jun;28(6):654-662. doi: 10.3171/2017.9.SPINE17494. Epub 2018 Mar 9.

19.  Freyschlag CF, Krieg SM, Kerschbaumer J, Pinggera D, Forster MT, Cordier D, Rossi M, Miceli G, Roux A, Reyes A, Sarubbo S, Smits A, Sierpowska J, Robe PA, Rutten GJ, Santarius T, Matys T, Zanello M, Almairac F, Mondot L, Jakola AS, Zetterling M, Rofes A, von Campe G, Guillevin R, Bagatto D, Lubrano V, Rapp M, Goodden J, De Witt Hamer PC, Pallud J, Bello L, Thomé C, Duffau H, Mandonnet. Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging. J Neurooncol. 2018 Sep;139(3):699-711. doi: 10.1007/s11060-018-2916-3. Epub 2018 Jul 10.

20.  Klughammer J, Kiesel B, Roetzer T, Fortelny N, Kuchler A, Nenning KH, Furtner J, C. Sheffield N, Datlinger P, Peter N, Nowosielski M, Augustin M, Mischkulnig M, Ströbel T, Alpar D, Ergüner B, Senekowitsch M, Moser P, Freyschlag CF, Kerschbaumer J, Thomé C, Grams AE, Stockhammer G, Kitzwoegerer M, Oberndorfer S, Marhold F, Weis S, Trenkler J, Buchroithner J, Pichler J, Haybaeck J, Krassnig S, Madhy Ali K, von Campe G, Payer F, Sherif C, Preiser J, Hauser T, Winkler PA, Kleindienst W, Würtz F, Brandner-Kokalj T, Stultschnig M, Schweiger S, Dieckmann K, Preusser M, Langs G, Baumann B, Knosp E, Widhalm G, Marosi C, Hainfellner JA, Woehrer A, Bock C. The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nat Med. 2018 Oct;24(10):1611-1624. doi: 10.1038/s41591-018-0156-x. Epub 2018 Aug 27.

21.  Pinggera D, Kerschbaumer J, Bauer M, Riedmann M, Conrad M, Brenner E, Thomé C, Freyschlag CF Accuracy validation of neuronavigation comparing headholder-based system with head-mounted array. A cadaveric study. World Neurosurg. 2018 Dec;120:e313-e317. doi: 10.1016/j.wneu.2018.08.059. Epub 2018 Aug 23.

22.  Freyschlag CF, Boehme C, Bauer M, Kerschbaumer J, Pinggera D, Riedmann M, Unterhofer C, Grams AE, Knoflach M, Thomé C. The Volume of Ischemic Brain Predicts Poor Outcome in Patients with Surgically Treated Malignant Stroke. World Neurosurg. 2019 Mar;123:e515-e519. doi: 10.1016/j.wneu.2018.11.197. Epub 2018 Nov 29.

23.  Kerschbaumer J, Pinggera D, Steiger R, Rietzler A, Wöhrer A, Riedmann M, Grams AE, Thomé C, Freyschlag CF. Results of Phosphorus Magnitic resonance spectroscopy for brain metastases correlates with histopathological results. World Neurosurg. 2019 Jul;127:e172-e178. doi: 10.1016/j.wneu.2019.03.041. Epub 2019 Mar 14.

24.  Staartjes VE, Broggi M, Zattra CM, Vasella F, Velz J, Schiavolin S, Serra C, Bartek J, Fletcher-Sandersjöö A, Förander P, Kalasauskas D, Renovanz M, Ringel F, Brawanski KR, Kerschbaumer J, Freyschlag CF, Jakola AS, Sjåvik K, Solheim O, Schatlo B, Sachkova A, Bock HC, Hussein A, Rohde V, Broekman MLD, Nogarede CO, Lemmens CMC, Kernbach JM, Neuloh G, Bozinov O, Krayenbühl N, Sarnthein J, Ferroli P, Regli L, Stienen MN; FEBNS. Development and external validation of a clinical prediction model for functional impairment after intracranial tumor surgery. J Neurosurg. 2020 Jun 12;134(6):1743-1750. doi: 10.3171/2020.4.JNS20643.

25.  Kiesel B, Thomé CM, Weiss T, Jakola AS, Darlix A, Pellerino A, Furtner J, Kerschbaumer J, Freyschlag CF, Wick W, Preusser M, Widhalm G, Berghoff AS. Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters Committee. BMC Cancer. 2020 May 12;20(1):410. doi: 10.1186/s12885-020-06897-z.

26.  Pinggera D, Steiger R, Bauer M, Kerschbaumer J, Luger M, Beer R, Rietzler A, Grams AE, Gizewski ER, Thomé C, Petr O. Cerebral Energy Status and Altered Metabolism in Early Severe TBI: First Results of a Prospective 31 P-MRS Feasibility Study. Neurocrit Care. 2021 Apr;34(2):432-440. doi: 10.1007/s12028-020-01042-x.

27.  Kerschbaumer J, Pinggera D, Holzner B, Delazer M, Bodner T, Karner E, Dostal L, Kvitsaridze I, Minasch D, Thomé C, Seiz-Rosenhagen M, Nevinny-Stickel M, Freyschlag CF. Sector irradiation vs. whole brain irradiation after resection of singular or solitary brain metastasis -a prospective randomized monocentric trial. Front Oncol. 2020 Nov 24;10:591884. doi: 10.3389/fonc.2020.591884. eCollection 2020.

28.  Walchhofer LM, Steiger R, Rietzler A, Kerschbaumer J, Freyschlag CF, Stockhammer G, Gizewski EK, Grams AE. Phosphorous Magnetic Resonance Spectroscopy to Detect Regional Differences of Energy and Membrane Metabolism in Naive Glioblastoma Multiforme. Cancers (Basel). 2021 May 26;13(11):2598. doi: 10.3390/cancers13112598.

29.  Yang Y, Zeitlberger AM, Neidert MC, Staartjes VE, Broggi M, Zattra CM, Vasella F, Velz J, Schiavolin S, Bartek J Jr, Fletcher-Sandersjöö A, Förander P, Kalasauskas D, Renovanz M, Ringel F, Brawanski KR, Kerschbaumer J, Freyschlag CF, Jakola AS, Sjåvik K, Solheim O, Schatlo B, Sachkova A, Bock HC, Hussein A, Rohde V, Broekman MLD, Nogarede CO, Lemmens CMC, Kernbach JM, Neuloh G, Krayenbühl N, Ferroli P, Regli L, Bozinov O, Stienen MN. The association of patient age with postoperative morbidity and mortality following resection of intracranial tumors. Brain Spine. 2021 Oct 21;1:100304. doi: 10.1016/j.bas.2021.100304. eCollection 2021.

30.  Heugenhauser J, Iglseder S, Muigg A, Kerschbaumer J, Stockhammer G, Nowosielski M, Unterberger I. Perampanel for the treatment of brain tumor and SMART-syndrome related epilepsy. J Neurol Sci. 2021 Apr 15;423:117386. doi: 10.1016/j.jns.2021.117386. Epub 2021 Mar 5.

31.  Pinggera D, Kerschbaumer J, Grassner L, Demetz M, Hartmann S, Thomé C. Effect of the COVID-19 pandemic on patient presentation and perception to a neurosurgical outpatient clinic. World Neurosurg. 2021 May;149:e274-e280. doi: 10.1016/j.wneu.2021.02.037. Epub 2021 Feb 18.

32.  Regodić M, Freyschlag CF, Kerschbaumer J, Galijašević M, Hörmann R, Freysinger W. Novel microscope-based visual display and nasopharyngeal registration for auditory brainstem implantation: a feasibility study in an ex vivo model. Int J Comput Assist Radiol Surg. 2022 Feb;17(2):261-270. doi: 10.1007/s11548-021-02514-x. Epub 2021 Nov 18.

33.  Mangesius J, Seppi T, Bates K, Arnold CR, Minasch D, Mangesius S, Kerschbaumer J, Lukas P, Ganswindt U, Nevinny-Stickel M. Hypofractionated and single-fraction radiosurgery for brain metastases with sex as a key predictor of overall survival. Sci Rep. 2021 Apr 21;11(1):8639. doi: 10.1038/s41598-021-88070-5.

34.  Kocher F, Seeber A, Kerschbaumer J, Schmidt S, Wolf D, Feistritzer C. Case report: successful perioperative management of patients with haemophilia A using an extended half-life fStactor VIII (Efmoroctocog alfa) during neurosurgical procedures. Ther Adv Hematol. 2021 Mar 31;12:2040620721993686. doi: 10.1177/2040620721993686. eCollection 2021.

35.  Galijasevic M, Steiger R, Radovic I, Birkl-Toeglhofer AM, Birkl C, Deeg L, Mangesius S, Rietzler A, Regodic M, Stockhammer G, Freyschlag CF, Kerschbaumer J, Haybaeck J, Grams AE, Gizewski ER. Phosphorus Magnetic Resonance Spectroscopy and molecular markers in IDH1 Wild Type glioblastoma. Cancers (Basel). 2021 Jul 16;13(14):3569. doi: 10.3390/cancers13143569. 

36.  Nowosielski M, Goebel G, Iglseder S, Steiger R, Ritter L, Stampfl D, Heugenhauser J, Kerschbaumer J, Gizewski ER, Freyschlag CF, Stockhammer G, Scherfler C. ADC textural features in patients with single brain metastases improve clinical risk models. Clin Exp Metastasis. 2022 Jun;39(3):459-466. doi: 10.1007/s10585-022-10160-z. Epub 2022 Apr 8.

37.  Pinggera D, Steiger R, Bauer M, Kerschbaumer J, Beer R, Rietzler A, Grams AE, Gizewski ER, Thomé C, Petr O. Repeated 31P-Magnetic Resonance Spectroscopy in Severe Traumatic Brain Injury: Insight into Cerebral Energy Status and Altered Metabolism. J Neurotrauma. 2021 Oct 15;38(20):2822-2830. doi: 10.1089/neu.2021.0143. Epub 2021 Aug 27.

38.  Kerschbaumer J, Demetz M, Krigers A, Nevinny-Stickel M, Thomé C, Freyschlag CF. Risk factors for radiation necrosis in patients undergoing cranial stereotactic radiosurgery. Cancers (Basel). 2021 Sep 22;13(19):4736. doi: 10.3390/cancers13194736.

39.  Krigers A, Moser P, Demetz M, Kerschbaumer J, Brawanski KR, Fritsch H, Thomé C, Freyschlag CF. The relationship between Connexin-43 expression and Ki67 in non-glial CNS tumors. Int J Biol Markers. 2023 Mar;38(1):46-52. doi: 10.1177/03936155221143138. Epub 2023 Feb 1.

40.  Abramovic A, Demetz M, Krigers A, Bauer M, Lener S, PInggera D, Kerschbaumer J, Hartmann S, Fritsch H, Thomé C, Freyschlag CF. Surgeon’s comfort: the ergonomics of a robotic exoscope using a head-mounted display. Brain Spine. 2021 Dec 28;2:100855. doi: 10.1016/j.bas.2021.100855. eCollection 2022.

41.  Grams AE, Mangesius S, Steiger R, Radovic I, Rietzler A, Walchhofer LM, Galijašević M, Mangesius J, Nowosielski M, Freyschlag CF, Kerschbaumer J, Gizewski ER. Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation. Curr Oncol. 2021 Dec 1;28(6):5041-5053. doi: 10.3390/curroncol28060424.

42.  Krigers A, Pinggera D, Demetz M, Kornberger LM, Kerschbaumer J, Thomé C, Freyschlag CF. The Routine Application of Tumor-Treating Fields in Glioblastoma WHO° IV. Front Neurol. 2022 Jun 16;13:900377. doi: 10.3389/fneur.2022.900377. eCollection 2022.

43.  Morandi EM, Pinggera D, Kerschbaumer J, Rauchenwald T, Winkelmann S, Thomé C, Pierer G, Wolfram D. Correction of temporal hollowing after craniotomy by autologous fat grafting. A single-center experience. World Neurosurg. 2022 Aug;164:e784-e791. doi: 10.1016/j.wneu.2022.05.049. Epub 2022 May 18.

44.  Mangesius J, Mangesius S, Demetz M, Uprimny C, Di Santo P, Galijasevic M, Minasch D, Gizewski ER, Ganswindt U, Virgolini I, Thomé C, Freyschlag CF, Kerschbaumer J. A multi-disciplinary approach to diagnosis and treatment of radionecrosis in malignant Gliomas and cerebral metastases. Cancers (Basel). 2022 Dec 19;14(24):6264. doi: 10.3390/cancers14246264.

45.  Kerschbaumer J, Demetz M, Krigers A, Pinggera D, Spinello A, Thomé C, Freyschlag CF. Mind the gap – The use of sodium fluoresceine for resection of brain metastases to improve the resection rate. Acta Neurochir (Wien). 2022 Nov 11. doi: 10.1007/s00701-022-05417-1. Acta Neurochir (Wien). 2023 Jan;165(1):225-230. doi: 10.1007/s00701-022-05417-1.Epub 2022 Nov 11.

46.  Klingenschmid J, Krigers A, Kerschbaumer J, Thomé C, Pinggera D, Freyschlag CF. Surgical management of malignant glioma in the elderly. Front Oncol. 2022 May 26;12:900382. doi: 10.3389/fonc.2022.900382. eCollection 2022.

47.  Kerschbaumer J, Krigers A, Demetz M, Pinggera D, Klingenschmid J, Pichler N, Thomé C, Freyschlag CF. The Clinical Frailty Scale as useful tool in patients with brain metastases. J Neurooncol. 2022 May;158(1):51-57. doi: 10.1007/s11060-022-04008-5. Epub 2022 Apr 13.

48.  Klingenschmid J, Krigers A, Pinggera D, Kerschbaumer J, Thomé C, Freyschlag CF. The Clinical Frailty Scale as predictor of overall survival after resection of high-grad glioma. J Neurooncol. 2022 May;158(1):15-22. doi: 10.1007/s11060-022-04001-y. Epub 2022 Apr 25.

49.  Krigers A, Demetz, M, Moser P, Kerschbaumer J, Brawanski, KR, Fritsch H, Thomé C, Freyschlag CF. Impact of GAP-43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas. Sci Rep. 2023 Feb 4;13(1):2024. doi: 10.1038/s41598-023-29298-1.

50.  Galijasevic M, Steiger R, Mangesius S, Mangesius J, Kerschbaumer J, Freyschlag CF, Stockhammer G, Nowosielski M, Gruber N, Janjic T, Gizewski ER, Grams AE. Magnetic Resonance Spectroscopy in Diagnosis and Follow-up of Gliomas: State-of-the-Art. Cancers (Basel). 2022 Jun 29;14(13):3197. doi: 10.3390/cancers14133197.

51.  Mangesius J, Seppi T, Arnold CR, Mangesius S, Wagner M, Bates K, Kerschbaumer J, Minasch D, Lukas P, Nevinny-Stickel M, Ganswindt U. Prognosis versus actual outcome in SRS of brain metastases: reliability of common prognostic parameters and indices. Curr. Oncol. 2024, 31, 1739-1751. 

52.  Ladenhauf V, Galijasevic M, Kerschbaumer J, Freyschlag CF, Stockhammer G, Haybaeck J, Gizewski ER, Grams AE. Peritumoral ADC-calues correlate with the MGMT-methylation status in patients with glioblastoma. Cancers (Basel). 2023 Feb 22;15(5):1384. doi: 10.3390/cancers15051384.

53.  Kerschbaumer J, Freyschlag, Petr O, Adage T, Breitenbach J, Wessels L, Wolf S, Hecht N, Gempt J, Wostrack M, Gmeiner, Gollwitzer, Stefanits, Bendszus, Gruber, Meyer, Vajkoczy, Thomé. A single ascending dose safety, tolerability and PK study of NicaPlant in aSAH patients undergoing aneurysm clipping – a randomized clinical trial. Brain Spine. 2023 Sep 18;3:102673. doi: 10.1016/j.bas.2023.102673. eCollection 2023. PMID: 38021019

54.  Iglseder S, Iglseder A, Beliveau V, Heugenhauser J, Kerschbaumer J, Gizewski ER, Stockhammer G, Uprimny C, Virgolini I, Dudas J, Nevinny-Stickel M, Nowosielski M, Scherfler C. Analysis of somatostatin receptor subtype expression and radiomics from apparent diffusion coefficient MRI maps represents standardized uptake values (SUV) of 68Gallium DOTATOC PET in patients with meningioma, a translational study. J Neurooncol. 2023 Sep 14. Doi: 10.1007/s11060-023-04414-3.

55.  Demetz M, Krigers A, Moser P, Kerschbaumer J, Thomé C, Freyschlag CF. Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival. J Neurooncol. 2023 Apr;162(2):397-405. doi: 10.1007/s11060-023-04301-x. Epub 2023 Apr 12. 

56.  Demetz M, Mangesius J, Krigers A, Nevinny-Stickel M, Thomè C, Freyschlag CF, Kerschbaumer J. Tumor location impacts the development of radiation necrosis in benign intracranial tumors. Cancers (Basel). 2023 Sep 28;15(19):4760. doi: 10.3390/cancers15194760

57.  Demetz M, Abramovic A, Krigers A, Bauer M, Lener S, Pinggera D, Kerschbaumer J, Hartmann S, Fritsch H, Thomé C, Freyschlag CF. Cadaveric study of ergonomics and performance using a robotic exoscope with a head-mounted display in spine surgery. J Robot Surg. 2024 Jan 10;18(1):6. Doi: 10.1007/s11701-023-01777-7

58.  Klingenschmid J, Schön V, Pinggera D, Kerschbaumer J, Grams AE, Thome C, Krigers A, Freyschlag CF. The prognostic relevance of temporal muscle thickness compared to functional scales in patients with high grade glioma. Front Oncol. 2023 Aug 31;13:1237105. Doi: 10.3389/fonc.2023.1237105. eCollection 2023

59.  Wessels L, Wolf S, Adage Tm Breitenbach J, Thomé C, Kerschbaumer J, Bendszus M, Gmeiner M, Gruber A, Mielke D, Rohde V, Wostrack M, Gempt J, Bavinzski G, Hirschmann D, Vajkoczy P, Hecht N. A Safety and Efficacy Study of NicaPlant in Aneurysmal Subarachnoid Heamorrhage Patients Undergoing Aneurysm Clipping. JAMA Neurol. 2024 Aug 19. Doi: 10.1001/jamaneurol.2024.2564. Online ahead of print. PMID: 39158893

60.  Klingenschmid J, Krigers A, Pinggera D, Kerschbaumer J, Pichler N, Schön V, Demetz M, Grams AE, Thomé C, Freyschlag CF. Temporal Muscle Thickness Compared to Functional Scales as a Prognostic Parameter in Patients with Brain Metastases. Cancers (Basel) 2024 Apr 25;16,1660. https://doi.org/10.3390/cancers16091660 

61.  Wasilewski D, Araceli T, Rafaelian A, Demetz M, Asey B, Ersoy TF, Dauth A, Neumeister A, Peukert R, Poeser P, Bukatz J, Shaked Z, Jelgersma C, Früh A, Xu R, Misch M, Capper D, Ehret F, Frost N, Bullinger L, Keilholz U, Senft C, Schmidt L, Krenzlin H, Ringel F, Port A, Meyer H, Gempt J, Kerschbaumer J, Freyschlag CF, Thome C, Simon M, Dubinski D, Freiman T, Schmidt NO, Proescholdt M, Vajkoczy P, Onken J. Dexamethasone practice variation and impact of perioperative dexamethasone on patient outcome in resected brain metastases. Jama Netw Open 2025 Apr 1,8(4):e254689. Doi: 10.1001(`/jamanetworkopen.2025.4689

62.  Demetz M, Krigers A, Uribe-Pacheco R, Pinggera D, Klingenschmid J, Thome C, Freyschlag CF, Kerschbaumer J. The role of postoperative blood pressure management in early postoperative hemorrhage in awake craniotomy glioma patients. Neurosurg Rev. 2024 Aug;47(1):452. Doi: 10.1007/s10143-024-02661-0. PMID: 339168945 

63.  Demetz M, Hecker C, Salim HA, Krigers A, Steinbacher J, Machegger L, Kerschbaumer J, Cuchta M, Pöppe J, Geiger P, Spinello A, Kraus TFJ, Griessenauer CJ, Thomé C, Freyschlag CF, Schwartz C. Epilepsy as primary tumor manifestation correlates with patient status, age, and tumor volume but not with survival in elderly glioblastoma patients: a retrospective bicentric analysis. Neurosurg Rev. 2025 Feb 24;48(1);264, doi: 10.1007/s10143-025-03397-1. PMID: 39994084

64.  Hubertus V, Viezens L, Stangenberg M, Früh AM, Meyer HS, Liang R, Kramer A, Orban C, Kerschbaumer J, Kunze B, Telera S, Miller H, Entenmann CJ, von Bronewski EJ, Buhre C, Leonhardt LG, Willenbacher W, Kvitsaridze I, Laue D, Pumberger M, Keller T, Acker G, Krönke J, Blau IW, Keller U, Ringel F, Thomé C, Meyer B, Vajkoczy P, Dreimann M, Onken JS.  Practive variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group. J Neurooncol. 2025 Sep;174(3):765*777.doi: 10.1007/s11060-025-05085-y. Epub 2025 Jun13. PMID: 40512280

65.  Demetz M, Krigers A, Klingenschmid J, Thome C, Freyschlag CF, Kerschbaumer J. Socioeconomic Influences on Survival Outcome in IDH- wildtype Glioma Patients: Examining the Role of Age, Education, and Lifestyle Factors. Acta Neurochir (Wien). 2025 Jun 27;167(1):178. Doi: 10.1007/s00701-025-06594-53

66.  Mangesius J, Kremser C, Birkl C, Yanick Weber M, Wagner M, Vorbach S, Kerschbaumer J, Seppi T, Ganswindt U, Gizewski E, Mangsius S. Optimizing MRI Protocols for Brain Radiosurgery: The Role of Sequence and Contrast Agent Timing. Invest Radiol. 2025 Sep 22. doi: 10.1097/RLI.0000000000001238. Online ahead of print. PMID: 40980938

67.   Uribe-Pacheco R, Abramovic A, Demetz M, Krigers A, Gmeiner R, Bauer M, Lener S, Pinggera D, Kerschbaumer J, Thomé C, Freyschlag CF. Performance and adaptability comparison between medical students and experienced neurosurgeons using a robotic exoscope with a head-mounted display. J Robot Surg. 2025 Jun 12;19(1):283. doi: 10.1007/s11701-025-02430-1. PMID: 40504296

69.  Berghoff AS, Mair MJ, Spiro Z, Malak CA, El-Heliebi A, Eckert F, Furtner J, König F, Leibetseder A, Nowosielski M, Oberndorfer S, Prietl B, Pichler J, Pieber TR, Spiegl-Kreinecker S, Urbanic Purkart T, Wöhrer A, Widhalm G, Preusser M, ATTRACT study group. Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT). Neurooncol Adv. 2025 Mar 7;7(1):vdaf056. Doi: 10.1093/noajnl/vdaf056.eCollection 2025 Jan-Dec

70. Demetz M, Krigers A, Miller-Michlits A, Wöhrer A, Thome C, Freyschlag CF, Kerschbaumer J. Multiple Primaries: Differences in Survival of Patients with Glioma with or Without Second Malignancies. Cancers (Basel). 2025 Nov 6;17(21):3584. Doi: 10.3390/cancers17213584. PMID: 41228375